EUVIMEDEUVIMED entdecken
Crossref

Short- and Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis and Muscle Loss

Nicol Bernardinello, Gioele Castelli, Giulia Grisostomi, Elisabetta Cocconcelli, Antonella Modugno, Matteo Daverio, Paolo Spagnolo, Roberto Stramare, Chiara Giraudo, Elisabetta Balestro

Respiration · 04.12.2025 · 105 (6) · 633-641

DOI: 10.1159/000549895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiration, online erschienen am 04.12.2025. Verfasst von Nicol Bernardinello und 9 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, Padova, Italy, nicol.bern…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Sarcopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Loss of muscle mass and sarcopenia are associated with poor prognosis in chronic respiratory illnesses and are currently emerging as coexisting conditions that deserve attention in patients with idiopathic pulmonary fibrosis (IPF). However, the exact impact of muscle changes in this deadly disease is not entirely understood. Our study aimed to investigate the role of muscle loss/myosteatosis assessed by computed tomography in the short- and long-term survival of patients with IPF treated with antifibrotics.

Methods

Ninety-six patients with IPF (16 females, 80 males) were retrospectively enrolled between March 2014 and December 2022. Demographic, functional, and radiological data were collected at diagnosis. Area and density of the paravertebral muscle at the level of the 12th thoracic vertebra were collected, and myosteatosis was defined as Hounsfield Unit (Hu) value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisSarcopeniaHumansFemaleMaleAgedRetrospective StudiesTomography, X-Ray ComputedMiddle AgedAged, 80 and overPrognosisSurvival RateAntifibrotic Agents

Stichwörter der Autor:innen

Computed tomographyIdiopathic pulmonary fibrosisMyosteatosisRadiomics

Substanzen

Antifibrotic Agents

Autor:innen und Institutionen

  • Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, Padova, Italy, nicol.bernardinello@unipd.it.
  • Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, Padova, Italy.
  • Unit of Advanced Clinical and Translational Imaging, Department of Cardiac, Thoracic, Vascular Science, and Public Health, University of Padova, Padova, Italy.

Zitieren

APA

Bernardinello, N., Castelli, G., Grisostomi, G., Cocconcelli, E., Modugno, A., Daverio, M., Spagnolo, P., Stramare, R., Giraudo, C., & Balestro, E. (2025). Short- and Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis and Muscle Loss. Respiration, 105(6), 633-641. https://doi.org/10.1159/000549895

Vancouver

Bernardinello N, Castelli G, Grisostomi G, Cocconcelli E, Modugno A, Daverio M, et al. Short- and Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis and Muscle Loss. Respiration. 2025;105(6):633-641. doi:10.1159/000549895

BibTeX
@article{Bernardinello2025,
  author = {Bernardinello, Nicol and Castelli, Gioele and Grisostomi, Giulia and Cocconcelli, Elisabetta and Modugno, Antonella and Daverio, Matteo and Spagnolo, Paolo and Stramare, Roberto and Giraudo, Chiara and Balestro, Elisabetta},
  title = {Short- and Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis and Muscle Loss},
  journal = {Respiration},
  year = {2025},
  volume = {105},
  number = {6},
  pages = {633--641},
  doi = {10.1159/000549895}
}
Kostenlos starten →